Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Singh, Namita
Patel, Minesh
Rabizadeh, Shervin
Dubinsky, Marla
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
321
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [41] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [42] The use of questionnaires in pediatric inflammatory bowel disease
    Blank C.
    Switzer G.E.
    Current Gastroenterology Reports, 2006, 8 (3) : 244 - 247
  • [43] Tacrolimus use in pediatric inflammatory bowel disease
    Chan, J.
    Foster, R.
    Leach, S. T.
    Day, A. S.
    Lemberg, D. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 151 - 152
  • [44] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [45] Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Pernes, Tyler
    Weiss, Alexandra
    Trivedi, Chinmay
    Patel, Manthankumar
    Medvedeva, Elina
    Xie, Dawei
    Yang, Yu-Xiao
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 734 - 744
  • [46] Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients
    Razvi, Mohammed A.
    Chowdhury, Reezwana
    Parian, Alyssa
    Melia, Joanna
    Truta, Brindusa
    Brant, Steve
    Dudley-Brown, Sharon
    Lazarev, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S417 - S418
  • [47] The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients
    Huseynzada, Sinakhanim
    Inel, Tuba Yuce
    Hajiyev, Farid
    Avsar, Aydan Koken
    Balci, Ali
    Akpinar, Hale
    Onen, Fatos
    Sari, Ismail
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (02) : 50 - +
  • [48] Vedolizumab in the Perioperative Management of Inflammatory Bowel Disease
    Lightner, Amy L.
    Loftus, Edward V., Jr.
    McKenna, Nicholas P.
    Raffals, Laura E.
    CURRENT DRUG TARGETS, 2019, 20 (13) : 1317 - 1322
  • [49] A product review of vedolizumab in inflammatory bowel disease
    Battat, Robert
    Dulai, Parambir S.
    Jairath, Vipul
    Vande Casteele, Niels
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2482 - 2490
  • [50] Predicting Response to Vedolizumab in Inflammatory Bowel Disease
    Meserve, Joseph
    Dulai, Parambir
    FRONTIERS IN MEDICINE, 2020, 7
12345